Topic: Eli Lilly and Company
Stockhouse | 2010-03-02 02:00:12
Focus on U.S. healthcare costs could be catalyst for biotech investment
U.S. Hospital study a very important (and unrecognized) catalyst for BioMS Success Heading into 2009 we selected (through my microcap.com newsletter and on Stockhouse) only one biotech to follow for the year. That was YM Biosciences (TSX: T.YM, Stock Forum) in the 30s and 40s ...
Reuters Life! Online Report | 2010-02-25 05:12:10
LONDON (Reuters) - Does this sound like anyone you know? Darryl is 35, has a steady job, a stable home and good marriage, enjoys a few beers in front of the TV most nights -- doesn't have what most people would call a drink problem. In the United States alone there are probably around 36 million Darryls, according to the National ...
AP Features | 2010-02-16 20:21:21
<div><p>Arkansas Attorney General Dustin McDaniel says the state has reached an $18.5 million settlement with Eli Lilly &amp; Co. over improper marketing of an anti-psychotic medication.</p><p>McDaniel said Tuesday the settlement covers state Medicare spending on prescriptions for Zyprexa that shouldn't have been written.< ...
consumeraffairs.com | 2010-02-05 07:05:17
<div id="subtitle">Money arrives at critical time, state says</div><div><p>The State of Mississippi has recovered some much needed cash, as drug giant Eli Lilly has agreed to an $18.5 million fraud settlement over the drug Zyprexa.</p><p>The drug was only approved ...
